Wockhardt Limited

Symbol: WOCKPHARMA.BO

BSE

533.1

INR

Market price today

  • -9.3464

    P/E Ratio

  • 1.4697

    PEG Ratio

  • 81.77B

    MRK Cap

  • 0.00%

    DIV Yield

Wockhardt Limited (WOCKPHARMA-BO) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.58%

Operating Profit Margin

-0.03%

Net Profit Margin

-0.30%

Return on Assets

0.00%

Return on Equity

-0.51%

Return on Capital Employed

0.00%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO:Dr. Habil Fakhruddin Khorakiwala
Full-time employees:2740
City:Mumbai
Address:Wockhardt Towers
IPO:2000-04-18
CIK:

Wockhardt Limited, a pharmaceutical and biotech company, manufactures and markets pharmaceuticals, medicinal, and chemical products in India, the United States, the United Kingdom, Switzerland, Ireland, Mexico, Russia, and internationally. It develops various molecules primarily in the areas of infectious diseases, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules; and active pharmaceutical ingredients. The company's biopharmaceutical products include Glaritus, a long-acting biosimilar glargine; Wosulin, a recombinant human insulin; Wepox, an r-DNA erythropoietin; human insulin; and Biovac-B, a hepatitis B vaccine. Its pipeline also includes long-acting insulin analogues, concentrated insulins, GLP1 analogues, haemopoietins, biobetters and novel products, and delivery devices. It also provides contract manufacturing services. The company was founded in 1967 and is headquartered in Mumbai, India.

General Outlook

When we look at how much money they make before expenses, they keep 0.575% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.031%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.296%. This tells us they're good at keeping money after all costs.

Return on Investments

Wockhardt Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.507%.

Stock Prices

Wockhardt Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $609.95, while its low point bottomed out at $588. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Wockhardt Limited's stock market.

Profitability Ratios

WOCKPHARMA.BO profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -15.63% underscores its earnings before tax deductions. The effective tax rate stands at -22.86%, revealing its tax efficiency. The net income per EBT, 189.61%, and the EBT per EBIT, 509.41%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -3.07%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-15.63%
Effective Tax Rate-22.86%
Net Income per EBT189.61%
EBT per EBIT509.41%
EBIT per Revenue-3.07%

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -21.44, and free cash flow per share, -21.44, depict cash generation on a per-share basis. Lastly, the operating cash flow sales ratio, -0.11, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-21.44
Free Cash Flow per Share-21.44
Operating Cash Flow Sales Ratio-0.11
Free Cash Flow to Operating Cash Flow Ratio1.00

Debt and Leverage Ratios

An interest coverage of -0.29 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Interest Coverage-0.29

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 183.67, provides a glimpse into top-line earnings distributed across each share. Net income per share, -38.80, reflects the portion of profit attributed to each share. The book value per share, 232.81, represents the net asset value distributed per share, while the tangible book value per share, 105.30, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share183.67
Net Income Per Share-38.80
Book Value Per Share232.81
Tangible Book Value Per Share105.30
Shareholders Equity Per Share232.81
Interest Debt Per Share171.80
Capex Per Share-14.51

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -17.57%, indicates top-line expansion, while the gross profit growth, -21.00%, reveals profitability trends. EBIT growth, -654.84%, and operating income growth, -654.84%, offer insights into operational profitability progression. The net income growth, -129.10%, showcases bottom-line expansion, and the EPS growth, -91.70%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-17.57%
Gross Profit Growth-21.00%
EBIT Growth-654.84%
Operating Income Growth-654.84%
Net Income Growth-129.10%
EPS Growth-91.70%
EPS Diluted Growth-91.70%
Weighted Average Shares Growth19.50%
Weighted Average Shares Diluted Growth19.50%
Dividends per Share Growth-100.00%
Operating Cash Flow Growth-62.95%
Free Cash Flow Growth-127.86%
10-Year Revenue Growth per Share-61.10%
5-Year Revenue Growth per Share-43.60%
3-Year Revenue Growth per Share-22.11%
10-Year Operating CF Growth per Share-91.77%
5-Year Operating CF Growth per Share86.20%
3-Year Operating CF Growth per Share-80.34%
10-Year Net Income Growth per Share-128.92%
5-Year Net Income Growth per Share23.46%
3-Year Net Income Growth per Share-573.50%
10-Year Shareholders Equity Growth per Share2.28%
5-Year Shareholders Equity Growth per Share-2.05%
3-Year Shareholders Equity Growth per Share4.70%
10-Year Dividend per Share Growth per Share-100.00%
5-Year Dividend per Share Growth per Share-100.00%
Receivables Growth-17.67%
Inventory Growth-14.43%
Asset Growth-6.79%
Book Value per Share Growth-27.08%
Debt Growth-0.64%
R&D Expense Growth-1.40%
SGA Expenses Growth-25.61%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 70,181,184,917.8, captures the company's total value, considering both debt and equity. Income quality, -0.25, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.04, gauges operational efficiency, while the research and development to revenue, 5.33%, highlights investment in innovation. The ratio of intangibles to total assets, 27.92%, indicates the value of non-physical assets, and capex to operating cash flow, -136.60%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value70,181,184,917.8
Income Quality-0.25
Sales General and Administrative to Revenue0.04
Research and Development to Revenue5.33%
Intangibles to Total Assets27.92%
Capex to Operating Cash Flow-136.60%
Capex to Revenue-7.90%
Capex to Depreciation-83.27%
Stock-Based Compensation to Revenue0.04%
Graham Number450.84
Return on Tangible Assets-10.09%
Graham Net Net-204.37
Working Capital-12,270,000,000
Tangible Asset Value15,170,000,000
Net Current Asset Value-18,130,000,000
Invested Capital1
Average Receivables8,825,000,000
Average Payables8,940,000,000
Average Inventory7,135,000,000
Days Sales Outstanding110
Days Payables Outstanding285
Days of Inventory On Hand216
ROIC-3.09%
ROE-0.17%

Valuation Ratios

The price to sales ratio, 2.95, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -26.43, and price to operating cash flows, -24.83, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price to Sales Ratio2.95
Price Cash Flow Ratio-24.83
Price Earnings to Growth Ratio1.47
Enterprise Value Multiple41.89
Price to Operating Cash Flow Ratio-24.83
Price to Free Cash Flows Ratio-26.43
Price to Tangible Book Ratio1.47
Enterprise Value to Sales2.65
Enterprise Value Over EBITDA33.10
EV to Operating Cash Flow45.87
Earnings Yield-11.35%
Free Cash Flow Yield-1.14%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Wockhardt Limited (WOCKPHARMA.BO) on the BSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -9.346 in 2024.

What is the ticker symbol of Wockhardt Limited stock?

The ticker symbol of Wockhardt Limited stock is WOCKPHARMA.BO.

What is company IPO date?

IPO date of Wockhardt Limited is 2000-04-18.

What is company current share price?

Current share price is 533.100 INR.

What is stock market cap today?

The market cap of stock today is 81774341400.000.

What is PEG ratio in 2024?

The current 1.470 is 1.470 in 2024.

What is the number of employees in 2024?

In 2024 the company has 2740.